Small molecule restoration of wildtype structure and function of mutant p53 using a novel zinc-metallochaperone based mechanism
Fluoromax-4 spectrofluorimeter equipped with thermostated cuvette holder (Jobin-Yvon).
Fluorescence measurements were taken in a 1 cm by 1 cm quartz cuvette with excitation and emission slits of 3 nm and 4 nm respectively. All experiments were conducted at 10 ˚C unless otherwise noted.
ZMC1 -Zn 2+ binding stoichiometry titration
ZnCl 2 was titrated into a solution of 10 μM ZMC1 at room temperature (RT) and the absorbance at 370 nm monitored. The absorbance values were corrected for dilution, and the rise and plateau phases of the curve were fitted with lines. The point of intersection was used to determine the saturating stoichiometry of Zn 2+ to ZMC1.
Competition binding
Freshly purified R175H (5 μM), which co-purified with 0.6 equivalents of bound Zn 2+ , was incubated with increasing concentrations of 4-(2-pyridylazo)resorcinol (PAR, Sigma-Aldrich) and left to equilibrate at 10 ˚C for 1 h. The concentration of PAR 2 Zn complex was then measured by absorbance at 500 nm. Samples were blanked against equivalent PAR solutions without protein added. No additional Zn 2+ was released from the protein when denatured in 6 M guanidine-hydrochloride (Gdn-HCl), so we concluded that all available Zn 2+ was accounted for in our competition binding curve. The K d was determined by solving the following mass action and mass conservation equations in parallel as described [3] , followed by least squares minimization using a custom script written in MATLAB R2010a (MathWorks):
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Equilibrium Dialysis
Equal volumes of DBD at ~20 μM and a mixture of 20 μM/10μM ZMC1 and ZnCl 2 were loaded onto either side of an acrylic microdialysis chamber separated by a piece of 8000 MWCO dialysis tubing (BioDesignInc). The membrane was pretreated by boiling in 2% sodium bicarbonate buffer and 1 mM EDTA for 10 min to remove any excess Zn 2+ and rinsed thoroughly. Samples were shaken vigorously for 24 hrs, and the concentration of ZMC1 2 Zn complex on each side of the membrane was determined by absorbance at 370 nm using ϵ 370 = 1.4
x 10 4 M -1 cm -1 (where each concentration unit represents 1/2 of a ZMC1 2 Zn complex) as determined by our lab.
Arrested refolding
Arrested refolding experiments were performed as described previously with minor modifications [5] . DBD (25 μM) was denatured in buffer containing 5 M urea, and then rapidly 
Re-metallation
After apoization, DBD (30 μM) was incubated with a mixture of 60 μM ZnCl 2 and 120 μM EDTA, 180 μM ZMC1, or 180 μM NTA for 20 min on ice. Samples were then desalted and Zn 2+ content assayed as above. 
Zn

Synthesis of compound A6
Azetidine (85 mg, 1.5 mmol) was dissolved in 5 mL methylene chloride and diisopropylethylamine (195 mg, 1.50 mmol, 1.0 equiv.) was added followed by triphosgene (267 mg, 0.9 mmol, 0.6 equiv.) and the reaction mixture stirred at ambient temperature for 4 hrs to 
Where ΔA max is the absorbance change at saturating 
Stopped-Flow Kinetics
Rapid kinetic measurements were carried out on a Bio-Logic SFM4-Q/S stopped-flow device.
The mixing dead-time was ~2 ms. Absorbance was observed at 370 nm with a 2 nm bandpass.
At room temperature, pre-mixed solutions of ZMC1 and ZnCl 2 were mixed with an equal GCTGCAGCACGCCAATATATTGGGATATATTCGCTCTACTAGCT. DNA was labeled with biotin, using DNA 3' End Biotinylation Kit (Thermo Fisher Scientific/Pierce). Unlabeled DNA was used to compete the binding. Reaction mixture was incubated at 4 C for 10 min prior to addition of biotin labeled probes. Binding buffer was described before [6] . DNA binding reactions were carried out at 4 C for 20 min, and resulting DNA-protein complexes were separated on a 6% polyacrylamide gel (made with 30% Acrylamide/Bis Solution (37.5:1) (BioRad)) in 0.5× Tris-borate (without EDTA), running in 0.5× Tris-borate (without EDTA) buffer.
Complexes were visualized by LightShift Chemiluminescent EMSA Kit (Thermo Fisher Scientific/Pierce). NTA and EDTA were from Sigma.
Cell lines and culture conditions
TOV112D, SK-PN-DW, LN-18, SK-MEL-2, H1299 were cultured in DMEM with 10% FBS.
MCF7, H841, H2122, H1755, Hs700T were cultured in RPMI with 10% FBS. SKOV3 and HCT116 were cultured in McCoy's 5A with 5% FBS. GSH and NAC were from Sigma-Aldrich.
Viability assay
Viability assays were done according to the manufacture instruction of Guava ViaCount (Millipore). In brief, the cells (5x10 4 cells/well) were cultured in a 12-well plate to reach the 50-60% confluence on the second day when treated with serial dilutions of the compound. Cell growthwas measured by Guava ViaCount reagent and Guava PCA instrument after incubation for 3 days.
Transfection of p53 siRNA
The siRNA transfection is done with Lipofectamine 2000 (Invitrogen), following the manufacture's instuctions. The p53 siRNA was from SMARTpool (Thermo Fisher Scientific/Dharmacon).
Immunofluorescent staining
The cells were grown on the coverslip, followed by various treatments. The coverslips were fixed with 4% paraformaldehyde for 10 min and then permealized with 0.5% Triton-X100 for 5
min. The conformation of the mutant and WT p53 proteins were recognized specifically by the antibodies PAB1620 (1:50, recognizing WT conformation) and PAB240 (1:200, recognizing mutant conformation) stained overnight, respectively. The secondary antibody, goat anti-mouse IgG was incubated for 40 min. PAB1620 and PAB240 were from EMD Chemicals.
Immunoprecipitation (IP)
The cell lysates (500 g) with various treatments were subjected to immunoprecipitation with
ImmunoCruz Optima Immunoprecipitation reagent (Santa Cruz Biotechnology) using the antibody PAB240 (4 g). 
Western blot
The lysates (or immunoprecipitated products) were run on SDS-PAGE and transferred onto PVDF membranes. The detection of the protein level was done with the manufacture instruction (Western Lightning® Plus-ECL, Perkin-Elmer). The p21 antibody was from EMD Chemicals.
The actin antibody and the p53 (DO-1 and FL393) were from Santa Cruz Biotechnology.
Phospho-ATM, total ATM, Phospho-p53 (Ser15) and Phospho-p53 (Ser46) antibodies were from Cell Signaling.-H2AX antibody was from Abcam. p53-K120 acetylation was from Millipore.
The density in IP was determined using Adobe Photoshop and was expressed as the ratio of IP band to lysate band then relative to the control (no treatment).
8-oxy-dGUO staining
8-oxy-dGUO antibody was from Trevigen. The immunocytochemistry staining was followed the manufacturer's instruction. 
